Key terms
About CDIO
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CDIO news
Apr 19
6:51am ET
Cardio Diagnostics price target lowered to $1.35 from $4 at Benchmark
Apr 04
8:40am ET
Cardio Diagnostics enters nationwide telehealth agreement with Navierre
Apr 02
4:42pm ET
Cardio Diagnostics Unveils New Investor Engagement Materials
Mar 05
9:14am ET
Cardio Diagnostics announces issuance of patent from USPTO
Feb 07
8:38am ET
Cardio Diagnostics teams with FMS to deploy tests to certain Walmart locations
Jan 26
5:19pm ET
Cardio Diagnostics files $17M mixed securities shelf
No recent press releases are available for CDIO
CDIO Financials
Key terms
Ad Feedback
CDIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CDIO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
